RFS
LGND icon

Richardson Financial Services’s Ligand Pharmaceuticals LGND Stock Holding History

Richardson Financial Services’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.8K Sell
88
-150
-63% -$35.3K 0.02% 391
2026
Q1 		$47.5K Buy
238
+10
+4% +$1.98K 0.03% 304
2025
Q4 		$43.1K Buy
228
+18
+9% +$3.46K 0.01% 314
2025
Q3 		$37.2K Buy
210
+97
+86% +$14.4K 0.02% 311
2025
Q2 		$12.7K Buy
113
+36
+47% +$3.85K 0.01% 379
2025
Q1 		$8.1K Hold
77
– – 0.01% 407
2024
Q4 		$8.14K Buy
+77
New +$8.7K 0.01% 426

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Richardson Financial Services's LGND Position: Q2 2026 in Review

Richardson Financial Services reduced its Ligand Pharmaceuticals (LGND) stake by 63% in Q2 2026, selling an estimated $35.3K and leaving 88 shares worth $27.8K. The position accounts for 0.02% of the portfolio, ranked #391.

Richardson Financial Services first reported a position in LGND in Q4 2024 and has held it in 7 quarters since. The position peaked at $47.5K in Q1 2026. 417 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Richardson Financial Services held 88 shares of Ligand Pharmaceuticals worth $27.8K as of Q2 2026.
  • Richardson Financial Services sold 150 Ligand Pharmaceuticals shares in Q2 2026, an estimated $35.3K.
  • Ligand Pharmaceuticals made up 0.02% of Richardson Financial Services's portfolio in Q2 2026, its #391 holding.
  • Richardson Financial Services first reported a position in Ligand Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Richardson Financial Services's Ligand Pharmaceuticals position peaked at $47.5K in Q1 2026.
  • 417 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Richardson Financial Services's 13F filing for Q2 2026, filed 10 Aug 2026.